Home
Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 25/05/21
Trade details
- Type
- Insider sale
- Amount
- $15,549.36
- Shares · price
- 23,208 sh · $0.67 a share
- Held after
- 1,063,693 sh
- Trade date
- 25/05/19
- Filed
- 25/05/21
- Days to filing
- 2 days
Sold 2.1% of holdings
- Share of holding sold
- 2.1%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 25/04/19~25/06/18Howard W. Robin's recent trades
- Howard W. Robin
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$30.1K
418 sh
$30.1K
Filed 08/18
Traded 08/18
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$334.5K
5,500 sh
$334.5K
Filed 06/18
Traded 06/17
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$318K
5,303 sh
$318K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$285.2K
4,697 sh
$285.2K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$277.4K
4,500 sh
$277.4K
Filed 06/18
Traded 06/17